March 28 (Reuters) - China Shineway Pharmaceutical Group Ltd 2877.HK:
GROUP FY NET INCOME RMB 840 MILLION
GROUP FY GROSS MARGIN 75%
GROUP FY SALES RMB 3,780 MILLION
TO DECLARE FIRST INTERIM DIVIDEND FOR 2025 OF RMB36 CENTS PER SHARE
Further company coverage: 2877.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.